Drugs News and Research

RSS

World’s strongest acid may have a role in synthesizing pharmaceuticals

Researchers at the University of California, Riverside have discovered the world’s strongest acid. Remarkably it is also the gentlest acid. This non-toxic and non-corrosive acid may have a role in processes such as improving the quality of gasoline, developing polymers and synthesizing pharmaceuticals.

16 Nov 2004

Discovery of new compounds that may treat mucus build-up associated with cystic fibrosis

Preliminary studies show these compounds improve the flow of mucus through the respiratory tract, allowing airways to clear more quickly and efficiently.

14 Nov 2004

36% of cancer patients ages 65 and older participate in clinical trials

A new study finds that only 36% of cancer patients ages 65 and older participate in clinical trials, despite making up 60% of the U.S. cancer population. The study will be published November 15 in the Journal of Clinical Oncology (JCO).

14 Nov 2004

Hysteroscopic sterilization will save patients money compared to laparoscopic tubal ligation

Mayo Clinic gynecologists have discovered that hysteroscopic sterilization, a new method of plugging the fallopian tubes to prevent conception, will save patients money compared to laparoscopic tubal ligation, the most commonly used method of sterilization for women.

14 Nov 2004

Use of the drug etodolac instead of drugs like Celebrex or Bextra could save $40 million annually

People in search of pain relief who take the generic anti-inflammatory etodolac suffer 60 percent fewer gastrointestinal complications than those who take similar drugs, according to researchers at UT Southwestern Medical Center at Dallas and the Dallas Veterans Affairs Medical Center.

14 Nov 2004

Can poor countries help rich countries contain drug costs?

Rich countries could follow the lead of poor countries and adopt a more systematic way of selecting medicines for reimbursement, according to a paper in this week's BMJ.

14 Nov 2004

HIV drugs known as protease inhibitors also protect against Malaria

Scientists from The Queensland Institute of Medical Research (QIMR) have found that a group of HIV drugs known as protease inhibitors may also be effective for treating or preventing malaria.

11 Nov 2004

Effective research could prevent half of the world's deaths

Health systems research has the potential to produce dramatic improvements in health worldwide and to meet some of the major development challenges in the new millennium.

11 Nov 2004

Shp2 protein plays a critical role in obesity

A team of researchers led by The Burnham Institute's Gen-Sheng Feng, Ph.D. has discovered that a protein called Shp2 plays a critical role in obesity.

11 Nov 2004

Four major U.S. ethnic groups less likely to have cholesterol controlled

Compared with non-Hispanic whites, non-Hispanic blacks and Hispanics who qualify for cholesterol-lowering drug treatment are less likely to have their “bad” LDL cholesterol controlled to recommended levels, researchers reported at the American Heart Association’s Scientific Sessions 2004.

11 Nov 2004

Atorvastatin slows down mental decline and improves depressive symptoms in people with Alzheimer’s disease

The cholesterol-lowering drug atorvastatin slowed down mental decline and improved depressive symptoms in people with Alzheimer’s disease, according to a small pilot study reported at the American Heart Association’s Scientific Sessions 2004.

11 Nov 2004

Lorus Therapeutics allowed Canadian patent to protect anticancer drugs

Lorus Therapeutics today announced that its wholly owned subsidiary, GeneSense Technologies Inc., has been allowed a patent by the Canadian Patent Office entitled "Antitumor Antisense Sequences Directed Against R1 and R2 Components of Ribonucleotide Reductase."

10 Nov 2004

Bretylium tosylate has unique benefits for patients with acute myocardial infarction

An "old" drug has unique benefits for patients with acute myocardial infarction (AMI; commonly known as heart attack), a finding that may contribute to a new understanding of how heart attacks develop, according to an article in the September/October American Journal of Therapeutics.

10 Nov 2004

Obesity statistics are as bogus as weight-loss scams

The weight-loss industry is finding itself in the crosshairs of the Federal Trade Commission's "Operation Big Fat Lies" -- a crackdown on slimming down pills, powders and patches that are too good to be true. The Center for Consumer Freedom (CCF) recommends that grossly exaggerated statistics and hype from pharmaceutical and weight-loss companies about the nation's so-called "obesity epidemic" also be placed under the federal microscope.

10 Nov 2004

Calcium channel blocker reduces adverse cardiovascular events

The calcium channel blocker amlodipine decreases the risk of cardiovascular events (such as heart attack or heart-disease related deaths) in patients with coronary artery disease and normal blood pressure, as does the ACE inhibitor enalapril, but to a lesser extent, according to a study in the November 10 issue of JAMA.

10 Nov 2004

Stem cell gene linked to a portion of one of the most common childhood brain cancers

Scientists at Johns Hopkins have linked a stem-cell gene to a portion of one of the most common childhood brain cancers, opening the door to tailored therapies that block the gene's tumor-promoting ability.

10 Nov 2004

A new medication has dramatically reduced mortality among African-American patients suffering from heart disease

A new medication has dramatically reduced mortality among African-American patients suffering from heart disease, according to results of a study including UT Southwestern Medical Center at Dallas researchers.

9 Nov 2004

New strain of mice to study nicotine addiction

A team of investigators supported by the National Institute on Drug Abuse (NIDA), National Institutes of Health, has created a strain of mice scientists can use to study nicotine addiction and its associated behaviors.

9 Nov 2004

Discovery of new gene that protects against lung cancer

Cancer Research UK scientists have discovered a new gene that protects against lung cancer, according to a study published in the journal PNAS.

9 Nov 2004

FDA has warned consumers not to purchase or to consume Actra-Rx or Yilishen, promoted as "dietary supplements" for treating erectile dysfunction

The Food and Drug Administration today warned consumers not to purchase or to consume Actra-Rx or Yilishen, two products promoted and offered for sale on Web sites as "dietary supplements" for treating erectile dysfunction and enhancing sexual performance for men.

9 Nov 2004

Drugs News and Research

World’s strongest acid may have a role in synthesizing pharmaceuticals

Discovery of new compounds that may treat mucus build-up associated with cystic fibrosis

36% of cancer patients ages 65 and older participate in clinical trials

Hysteroscopic sterilization will save patients money compared to laparoscopic tubal ligation

Use of the drug etodolac instead of drugs like Celebrex or Bextra could save $40 million annually

Can poor countries help rich countries contain drug costs?

HIV drugs known as protease inhibitors also protect against Malaria

Effective research could prevent half of the world's deaths

Shp2 protein plays a critical role in obesity

Four major U.S. ethnic groups less likely to have cholesterol controlled

Atorvastatin slows down mental decline and improves depressive symptoms in people with Alzheimer’s disease

Lorus Therapeutics allowed Canadian patent to protect anticancer drugs

Bretylium tosylate has unique benefits for patients with acute myocardial infarction

Obesity statistics are as bogus as weight-loss scams

Calcium channel blocker reduces adverse cardiovascular events

Stem cell gene linked to a portion of one of the most common childhood brain cancers

A new medication has dramatically reduced mortality among African-American patients suffering from heart disease

New strain of mice to study nicotine addiction

Discovery of new gene that protects against lung cancer

FDA has warned consumers not to purchase or to consume Actra-Rx or Yilishen, promoted as "dietary supplements" for treating erectile dysfunction

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Top-Down Proteomics: Bridging the Genotype-to-Phenotype Gap

Bridging the Gap between Academia and Industry: The Power of Collaboration in Life Sciences

Latest News